Investigational Drug Information for CA-008
✉ Email this page to a colleague
What is the development status for investigational drug CA-008?
CA-008 is an investigational drug.
There have been 7 clinical trials for CA-008.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 25th 2019.
The most common disease conditions in clinical trials are Pain, Postoperative, Bunion, and Hernia, Ventral. The leading clinical trial sponsors are Concentric Analgesics and [disabled in preview].
There is one US patent protecting this investigational drug and twenty international patents.
Summary for CA-008
| US Patents | 1 |
| International Patents | 20 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2019-03-25) |
| Vendors | 6 |
Recent Clinical Trials for CA-008
| Title | Sponsor | Phase |
|---|---|---|
| Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair | Concentric Analgesics | Phase 1/Phase 2 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 | Concentric Analgesics | Phase 1/Phase 2 |
| Open-Label CA-008 (Vocacapsaicin) in Bunionectomy | Concentric Analgesics | Phase 2 |
Clinical Trial Summary for CA-008
Top disease conditions for CA-008
Top clinical trial sponsors for CA-008
US Patents for CA-008
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CA-008 | ⤷ Try a Trial | Prodrugs of phenolic TRPV1 agonists | CONCENTRIC ANALGESICS, INC. (San Francisco, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CA-008
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CA-008 | Argentina | AR102799 | 2034-11-25 | ⤷ Try a Trial |
| CA-008 | Australia | AU2015353532 | 2034-11-25 | ⤷ Try a Trial |
| CA-008 | Brazil | BR112017010950 | 2034-11-25 | ⤷ Try a Trial |
| CA-008 | Canada | CA2968061 | 2034-11-25 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
